Affiliation:
1. Department for Life Quality Studies, University of Bologna—C.so d’Augusto, 237, 47921 Rimini, Italy
Abstract
Angiogenesis and metastasis represent two challenging targets to combat cancer development in the later stages of its progression. Numerous studies have indicated the important role of natural products in blocking tumor angiogenesis signaling pathways in several advanced tumors. In recent years, the marine polysaccharides fucoidans emerged as promising anticancer compounds showing potent antitumor activity in both in vitro and in vivo models of different types of cancers. The objective of this review is to focus on the antiangiogenic and antimetastatic activities of fucoidans with special emphasis on preclinical studies. Independently from their source, fucoidans inhibit several angiogenic regulators, primarily vascular endothelial growth factor (VEGF). A glance towards fucoidans’ ongoing clinical trials and pharmacokinetic profile is provided to present the main challenges that still need to be addressed for their bench-to-bedside translation.
Subject
Drug Discovery,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science
Reference88 articles.
1. Current Cancer Epidemiology;Mattiuzzi;J. Epidemiol. Glob. Health,2019
2. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor;Zhao;Oncologist,2015
3. Hallmarks of Cancer: The next Generation;Hanahan;Cell,2011
4. Antiangiogenic Therapy in Oncology: Current Status and Future Directions;Jayson;Lancet,2016
5. Catanzaro, E., Greco, G., Potenza, L., Calcabrini, C., and Fimognari, C. (2018). Natural Products to Fight Cancer: A Focus on Juglans Regia. Toxins, 10.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献